Clinical Trial Update: Ocriplasmin for Vitreomacular Traction/Symptomatic Vitreomacular Adhesion [Phase 4]

View source ↗

Summary

Phase 4 trial update for ocriplasmin in vitreomacular traction and symptomatic vitreomacular adhesion; study completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitreomacular Adhesion
• Vitreomacular Traction

Drugs mentioned

• ocriplasmin (ocriplasmin)

Snippet

Sponsor: Alcon Research | Conditions: Vitreomacular Traction, Vitreomacular Adhesion | Phase 4 | Status: COMPLETED | Results posted: 2018-07-23